| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Pasteur Institute of Brussels, Department of Virology, Brussels, Belgium;
Gesellschaft für Biotechnologische Forschung, Braunschweig, Germany; and
Merck Research Laboratories, West Point, PA 19486
Using culture filtrate Ag-specific mAbs generated from
mycobacteria-infected H-2b haplotype mice, we have
previously identified three genes in the Mycobacterium
tuberculosis genome, encoding proteins homologous to the
periplasmic ATP-binding cassette phosphate-binding receptor PstS
of the phosphate-specific transport system of E. coli.
To define the potential vaccinal properties of these phosphate-binding
proteins, female C57BL/6 mice were injected i.m. with plasmid DNA
encoding PstS-1, PstS-2, or PstS-3 proteins from M.
tuberculosis and immunogenicity and protective efficacy against
i.v. challenge with M. tuberculosis H37Rv was analyzed.
Significant levels of highly Ag-specific Abs and Th1-type cytokines
IL-2 and IFN-
could be detected following vaccination with each of
the three genes. However, only mice vaccinated with PstS-3 DNA
demonstrated significant and sustained reduction in bacterial CFU
numbers in spleen and lungs for 3 mo after M.
tuberculosis challenge, as compared with CFU counts in mice
vaccinated with control DNA. Vaccination with PstS-2 DNA induced a
modest reduction in CFU counts in spleen only, whereas vaccination with
PstS-1 DNA was completely ineffective in reducing bacterial
multiplication. In conclusion, our results indicate that DNA
vaccination is a powerful and easy method for comparative screening of
potentially protective Ags from M. tuberculosis and that
the PstS-3 protein is a promising new subunit vaccine
candidate.
This article has been cited by other articles:
|
|
 |
|
  D. N. Harland, K. Chu, A. Haque, M. Nelson, N. J. Walker, M. Sarkar-Tyson, T. P. Atkins, B. Moore, K. A. Brown, G. Bancroft, et al. Identification of a LolC Homologue in Burkholderia pseudomallei, a Novel Protective Antigen for Melioidosis Infect. Immun., August 1, 2007; 75(8): 4173 - 4180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Semret, D. Bakker, N. Smart, I. Olsen, K. Haslov, and M. A. Behr Genetic Analysis of Mycobacterium avium Complex Strains Used for Producing Purified Protein Derivatives. Clin. Vaccine Immunol., September 1, 2006; 13(9): 991 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D'Souza, M. Romano, J. Korf, X.-M. Wang, P.-Y. Adnet, and K. Huygen Partial Reconstitution of the CD4+-T-Cell Compartment in CD4 Gene Knockout Mice Restores Responses to Tuberculosis DNA Vaccines. Infect. Immun., May 1, 2006; 74(5): 2751 - 2759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Beninati, A. Midiri, G. Mancuso, C. Biondo, M. Arigo, E. Gerace, S. Papasergi, M. Gambuzza, M. Boretti, W. Magliani, et al. Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci J. Exp. Med., January 23, 2006; 203(1): 111 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. PARIDA, K. HUYGEN, B. RYFFEL, and T. CHAKRABORTY Novel Bacterial Delivery System with Attenuated Salmonella typhimurium Carrying Plasmid Encoding Mtb Antigen 85A for Mucosal Immunization: Establishment of Proof of Principle in TB Mouse Model Ann. N.Y. Acad. Sci., November 1, 2005; 1056(1): 366 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-J. Ko, S.-Y. Ko, Y.-J. Kim, E.-G. Lee, S.-N. Cho, and C.-Y. Kang Optimization of Codon Usage Enhances the Immunogenicity of a DNA Vaccine Encoding Mycobacterial Antigen Ag85B Infect. Immun., September 1, 2005; 73(9): 5666 - 5674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Shin, C.-F. Chang, C.-D. Chang, S. P. McDonough, B. Thompson, H. S. Yoo, and Y.-F. Chang In Vitro Cellular Immune Responses to Recombinant Antigens of Mycobacterium avium subsp. paratuberculosis Infect. Immun., August 1, 2005; 73(8): 5074 - 5085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Garmory and R. W. Titball ATP-Binding Cassette Transporters Are Targets for the Development of Antibacterial Vaccines and Therapies Infect. Immun., December 1, 2004; 72(12): 6757 - 6763. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Romano, O. Denis, S. D'Souza, X.-M. Wang, T. H. M. Ottenhoff, J.-M. Brulet, and K. Huygen Induction of In Vivo Functional Db-Restricted Cytolytic T Cell Activity against a Putative Phosphate Transport Receptor of Mycobacterium tuberculosis J. Immunol., June 1, 2004; 172(11): 6913 - 6921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Stratmann, B. Strommenger, R. Goethe, K. Dohmann, G.-F. Gerlach, K. Stevenson, L.-l. Li, Q. Zhang, V. Kapur, and T. J. Bull A 38-Kilobase Pathogenicity Island Specific for Mycobacterium avium subsp. paratuberculosis Encodes Cell Surface Proteins Expressed in the Host Infect. Immun., March 1, 2004; 72(3): 1265 - 1274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Huygen On the Use of DNA Vaccines for the Prophylaxis of Mycobacterial Diseases Infect. Immun., April 1, 2003; 71(4): 1613 - 1621. [Full Text]
|
|
|
|
|
|
S. D'Souza, V. Rosseels, M. Romano, A. Tanghe, O. Denis, F. Jurion, N. Castiglione, A. Vanonckelen, K. Palfliet, and K. Huygen Mapping of Murine Th1 Helper T-Cell Epitopes of Mycolyl Transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis Infect. Immun., January 1, 2003; 71(1): 483 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D'Souza, V. Rosseels, O. Denis, A. Tanghe, N. De Smet, F. Jurion, K. Palfliet, N. Castiglioni, A. Vanonckelen, C. Wheeler, et al. Improved Tuberculosis DNA Vaccines by Formulation in Cationic Lipids Infect. Immun., July 1, 2002; 70(7): 3681 - 3688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Chambers, A. Williams, G. Hatch, D. Gavier-Widen, G. Hall, K. Huygen, D. Lowrie, P. D. Marsh, and R. G. Hewinson Vaccination of Guinea Pigs with DNA Encoding the Mycobacterial Antigen MPB83 Influences Pulmonary Pathology but Not Hematogenous Spread following Aerogenic Infection with Mycobacterium bovis Infect. Immun., April 1, 2002; 70(4): 2159 - 2165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Orihuela, J. Mills, C. W. Robb, C. J. Wilson, D. A. Watson, and D. W. Niesel Streptococcus pneumoniae PstS Production Is Phosphate Responsive and Enhanced during Growth in the Murine Peritoneal Cavity Infect. Immun., December 1, 2001; 69(12): 7565 - 7571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Al-Mariri, A. Tibor, P. Mertens, X. De Bolle, P. Michel, J. Godfroid, K. Walravens, and J.-J. Letesson Induction of Immune Response in BALB/c Mice with a DNA Vaccine Encoding Bacterioferritin or P39 of Brucella spp. Infect. Immun., October 1, 2001; 69(10): 6264 - 6270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. A. J. Fonseca, B. Benaissa-Trouw, M. van Engelen, C. A. Kraaijeveld, H. Snippe, and A. F. M. Verheul Induction of Cell-Mediated Immunity against Mycobacterium tuberculosis Using DNA Vaccines Encoding Cytotoxic and Helper T-Cell Epitopes of the 38-Kilodalton Protein Infect. Immun., August 1, 2001; 69(8): 4839 - 4845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Orme The search for new vaccines against tuberculosis J. Leukoc. Biol., July 1, 2001; 70(1): 1 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tanghe, S. D'Souza, V. Rosseels, O. Denis, T. H. M. Ottenhoff, W. Dalemans, C. Wheeler, and K. Huygen Improved Immunogenicity and Protective Efficacy of a Tuberculosis DNA Vaccine Encoding Ag85 by Protein Boosting Infect. Immun., May 1, 2001; 69(5): 3041 - 3047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tanghe, O. Denis, B. Lambrecht, V. Motte, T. van den Berg, and K. Huygen Tuberculosis DNA Vaccine Encoding Ag85A Is Immunogenic and Protective When Administered by Intramuscular Needle Injection but Not by Epidermal Gene Gun Bombardment Infect. Immun., July 1, 2000; 68(7): 3854 - 3860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Martin, A. T. Kamath, J. A. Triccas, and W. J. Britton Protection against Virulent Mycobacterium avium Infection following DNA Vaccination with the 35-Kilodalton Antigen Is Accompanied by Induction of Gamma Interferon-Secreting CD4+ T Cells Infect. Immun., June 1, 2000; 68(6): 3090 - 3096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. C. Turner, A. D. Roberts, A. A. Frank, S. W. Phalen, D. M. McMurray, J. Content, O. Denis, S. D'Souza, A. Tanghe, K. Huygen, et al. Lack of Protection in Mice and Necrotizing Bronchointerstitial Pneumonia with Bronchiolitis in Guinea Pigs Immunized with Vaccines Directed against the hsp60 Molecule of Mycobacterium tuberculosis Infect. Immun., June 1, 2000; 68(6): 3674 - 3679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lefevre, O. Denis, L. De Wit, A. Tanghe, P. Vandenbussche, J. Content, and K. Huygen Cloning of the Gene Encoding a 22-Kilodalton Cell Surface Antigen of Mycobacterium bovis BCG and Analysis of Its Potential for DNA Vaccination against Tuberculosis Infect. Immun., March 1, 2000; 68(3): 1040 - 1047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Arichi, T. Saito, M. E. Major, I. M. Belyakov, M. Shirai, V. H. Engelhard, S. M. Feinstone, and J. A. Berzofsky Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model PNAS, January 4, 2000; 97(1): 297 - 302. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
